Browse studies, page 420
Page 420 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Mental health in the UK during the COVID-19 pandemic: cross-sectional analyses from a community cohort study BMJ Open, 2020
- Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study BMC Medicine, 2020
- A prospective cohort study on the safety of checkpoint inhibitors in older cancer patients – the ELDERS study ESMO Open, 2021
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study Journal of Infection, 2020
- Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study The Lancet Haematology, 2020
- Proton pump inhibitors and risk of gastric cancer: population-based cohort study Gut, 2021
- Cohort Profile Update: Lifelines, a three-generation cohort study and biobank International Journal of Epidemiology, 2021
- Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study The Lancet, 2021
- Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study The Lancet Respiratory Medicine, 2021
- The China birth cohort study (CBCS) European Journal of Epidemiology, 2022
- Factors Associated With Long COVID Symptoms in an Online Cohort Study medRxiv, 2022
- Long-term exposure to ozone and cardiovascular mortality in China: a nationwide cohort study Lancet Planetary Health, 2022
- Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study British medical journal, 2021
- Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study British medical journal, 2021
- Validity and reproducibility of a food frequency questionnaire assessing food group intake in the PERSIAN Cohort Study Frontiers in Nutrition, 2023
- Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study Cardiovascular Diabetology, 2023
- Trends in prescribing volumes and costs of proton pump inhibitors in three outpatient specialties: a three-year retrospective study in a tertiary hospital in Thailand The International journal of pharmacy practice, 2023
- Improving clinical outcomes of Barrett's esophagus with high dose proton pump inhibitors and cryoablation Annals of medicine, 2023
- Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2019
- Technology for Adults with Intellectual Disability: Secondary Analysis of a Scoping Review Canadian journal of occupational therapy. Revue canadienne d'ergotherapie, 2023
- Comparing Efficacy and Safety of Empirical vs. Guided Therapy for Non-cardiac Chest Pain: A Pragmatic Randomized Trial Frontiers in Medicine, 2021
- Refractory gastroesophageal reflux disease Gastroenterology report, 2015
- Non-Carriers of Reduced-Function CYP2C19 Alleles are Most Susceptible to Impairment of the Anti-Platelet Effect of Clopidogrel by Proton-Pump Inhibitors: A Pilot Study Acta Cardiologica Sinica, 2016
- Refractory Gastroesophageal Reflux Disease: A Management Update Frontiers in medicine, 2021
- Cost-effective Analysis of Proton Pump Inhibitors in Long-term Management of Gastroesophageal Reflux Disease: A Narrative Review Hospital pharmacy, 2020
- Efficacy and Safety of Direct-acting Antivirals in Hepatitis C Virus-infected Patients Taking Proton Pump Inhibitors Journal of clinical and translational hepatology, 2017
- Novel approaches to inhibition of gastric acid secretion Current gastroenterology reports, 2010
- Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date Therapeutic advances in gastroenterology, 2018
- Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection The American journal of gastroenterology, 2020
- Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation Therapeutic advances in gastroenterology, 2017
- Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma Gastroenterology clinics of North America, 2022
- Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs JAMA network open, 2021
- The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer Cancer, 2019
- CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association Circulation, 2024
- Gastric acid suppressants and cognitive decline in people with or without cognitive impairment Alzheimer's & dementia (New York, N. Y.), 2022
- Risk of fractures in individuals with eosinophilic esophagitis: nationwide population-based cohort study Esophagus : official journal of the Japan Esophageal Society, 2022
- Long-term use of proton-pump inhibitor on Alzheimer's disease: a real-world distributed network analysis of six observational Korean databases using a Common Data Model Therapeutic advances in neurological disorders, 2022
- Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding Yonsei medical journal, 2020
- Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis Open heart, 2015
- Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021
- Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents The American journal of gastroenterology, 2016
- Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy Journal of clinical gastroenterology, 2020
- Review of recent evidence on the management of heartburn in pregnant and breastfeeding women BMC gastroenterology, 2022
- Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patients Pharmacogenomics, 2022
- Combination of esomeprazole and pirfenidone enhances antifibrotic efficacy in vitro and in a mouse model of TGFβ-induced lung fibrosis Scientific reports, 2022
- Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase Cancer letters, 2021
- Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study BMC pharmacology & toxicology, 2022
- Comparing the effects of four common drug classes on the progression of mild cognitive impairment to dementia using electronic health records Scientific reports, 2023
- Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors Chonnam medical journal, 2023
- Major Shifts in Acid Suppression Drug Utilization After the 2019 Ranitidine Recalls in Canada and United States Digestive diseases and sciences, 2023
- Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis Journal of clinical medicine, 2022
- Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis Therapeutic advances in medical oncology, 2022
- Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease Annals of medicine, 2023
- Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease PloS one, 2022
- The Association between Proton Pump Inhibitors and Myocardial Infarction: What Do Food and Drug Administration Data Tell Us? Journal of research in pharmacy practice, 2019
- Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced Melanoma Cancers, 2022
- Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer Thoracic cancer, 2024
- Updates in the Management of Erosive Esophagitis The Journal of family practice, 2023
- The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis Cancers, 2023
- Comparative Risk of Incidence and Clinical Outcomes of COVID-19 among Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Users: A Nationwide Retrospective Cohort Study 2021
- Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines Cureus, 2022
- Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk Medicina (Kaunas, Lithuania), 2023
- Association between proton pump inhibitor use and the risk of myocardial infarction: A cross-sectional study based on NHANES 2007 to 2018 Medicine, 2025
- Proton pump inhibitor concomitant use to prevent oxaliplatin-induced peripheral neuropathy: Clinical retrospective cohort study Pharmacotherapy, 2025
- Analysis of Upper Gastrointestinal Adverse Events Associated with Oral Anticoagulants and Potential Drug Interactions with Cardiovascular Drugs: Exploratory Study Using FDA Adverse Event Reporting System Pharmaceuticals (Basel, Switzerland), 2025
- Screening for Potential Drug-Drug Interactions in Patients Receiving Anticoagulant Therapy: A Comparison of Three Drug Interaction Databases for Consistency in Severity Rating, Evidence Classification, and Clinical Management Medicina (Kaunas, Lithuania), 2026
- Risk of asthma in individuals with eosinophilic esophagitis: Population-based cohort study with sibling analyses Clinical and translational allergy, 2025
- Association between acid-suppressant use and self-reported stroke BMC neurology, 2025
- Renal Outcomes With Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in CKD Kidney international reports, 2026
- Association between proton pump inhibitors use and risk of asthma in Korea: A prevalent new-user cohort study Medicine, 2024
- CYP2C19 genotypes and osteoporotic fractures in long-term users of proton pump inhibitors: A hospital-based study Clinical and translational science, 2023
- Real-World Effectiveness of Rebamipide on Gastritis Symptoms: A Patient-Focused Approach Clinical and translational science, 2025
- Oral P2Y12 Inhibitors: Victims or Perpetrators? A Focused Review on Pharmacokinetic, Clinically Relevant Drug Interactions European cardiology, 2025
- The Impact of Proton Pump Inhibitors on Pseudarthrosis Rates Following Multi-Level Lumbar Fusion Spine surgery and related research, 2026
- Effects of proton pump inhibitors on inflammatory bowel disease: An updated review World journal of gastroenterology, 2024
- Association between the use of proton pump inhibitors and serum PSA levels in the general U.S. population World journal of urology, 2025
- Association between Proton Pump Inhibitor Use and Risk of Incident Chronic Kidney Disease: Systematic Review and Meta-Analysis Biomedicines, 2024
- A Multicenter, Prospective Real-World Study of Simethicone-Activated Charcoal in Patients With Persistent Dyspeptic Symptoms Despite Acid Suppression (SIMAC Study) JGH open : an open access journal of gastroenterology and hepatology, 2026
- Inconsistency in the Association Between Proton Pump Inhibitor Use and Dementia Risk: An Updated Meta-Analysis Brain sciences, 2026
- Impact of Feeding Strategies With Acid Suppression on Esophageal Reflexes in Human Neonates With Gastroesophageal Reflux Disease: A Single-Blinded Randomized Clinical Trial Clinical and Translational Gastroenterology, 2020
- Synthetic mRNA Encoding VEGF-A in Patients Undergoing Coronary Artery Bypass Grafting: Design of a Phase 2a Clinical Trial Molecular Therapy: Methods & Clinical Development, 2020
- The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review Clinical Therapeutics, 2020
- Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial Journal of Allergy and Clinical Immunology, 2021
- Demographic and Baseline Characteristics of GERD Patients Based on Data From the Dexlansoprazole MR Clinical Trial Program Relative to Earlier Lansoprazole Trials: 16 The American Journal of Gastroenterology, 2009
- PP-089 A new ultra short regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in eradication of Helicobacter pylori: an open-label randomized clinical trial 2010
- Safety profile of dexlansoprazole MR, a proton pump inhibitor with a novel dual delayed release formulation: global clinical trial experience Alimentary Pharmacology and Therapeutics, 2009
- Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data American Journal of Gastroenterology, 2011
- Zinc Gluconate Induces Potentially Cancer Chemopreventive Activity in Barrett's Esophagus: A Phase 1 Pilot Study Digestive diseases and sciences, 2021
- The impact of comorbid gastroesophageal reflux disease on endoscopic sinus surgery quality-of-life outcomes International forum of allergy & rhinology, 2014
- Modulation of the oxidative plasmatic state in gastroesophageal reflux disease with the addition of rich water molecular hydrogen: A new biological vision Journal of cellular and molecular medicine, 2018
- ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial F1000Research, 2020
- Low-Dose Dextromethorphan for the Treatment of Fibromyalgia Pain: Results from a Longitudinal, Single-Blind, Placebo-Controlled Pilot Trial Journal of pain research, 2021
- Prevalence of CYP2C19 polymorphism in Bogotá, Colombia: The first report of allele *17 PloS one, 2021
- Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings Medicina oral, patologia oral y cirugia bucal, 2020
- pH Impedance Monitoring on Proton Pump Inhibitor Therapy Impacts Management Decisions in Proven GERD but Not in Unproven GERD Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2025
- Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of lansoprazole and gastroesophageal symptoms in Japanese renal transplant recipients classified as CYP2C19 extensive metabolizers and treated with tacrolimus International journal of clinical pharmacology and therapeutics, 2006
- Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (GERD): a prospective, multicenter, post-marketing observational study Clinical drug investigation, 2014
- Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19 Clinical pharmacology and therapeutics, 2002
- Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes European journal of clinical pharmacology, 2004
- Parameter Estimation and Estimability Analysis in Pharmaceutical Models with Uncertain Inputs AIChE Journal, 2023
